1.Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer.
Fariz NURWIDYA ; Fumiyuki TAKAHASHI ; Akiko MURAKAMI ; Kazuhisa TAKAHASHI
Cancer Research and Treatment 2012;44(3):151-156
Among all types of cancer, incidence of lung cancer remains the highest with regard to cancer-related mortality. Problems contributing to recurrence of the disease include metastasis and drug resistance. Mounting evidence has demonstrated involvement of epithelial mesenchymal transition (EMT) in cancer progression. EMT is a critical mechanism ensuring tissue remodeling during morphogenesis of multicellular organisms. Therefore, understanding of the biology of this process for identification of potential EMT-targeted therapeutic strategies for the benefit cancer patients is necessary. This review describes recent evidence of EMT involvement in drug resistance and metastasis of cancers, with an emphasis on lung cancer.
Biology
;
Drug Resistance
;
Epithelial-Mesenchymal Transition
;
Humans
;
Incidence
;
Lung
;
Lung Neoplasms
;
Morphogenesis
;
Neoplasm Metastasis
;
Recurrence
2.Skeletal related events in non-small cell lung cancer with bone metastases
Koji Sato ; Nobuhiro Saruki ; Hisashi Hosaka ; Tadashi Murakami ; Yuki Takada ; Akiko Matsunuma ; Kuniaki Suzuki ; Toshifumi Kazama ; Koichi Minato
Palliative Care Research 2010;5(2):145-151
Purpose: Bone is one of the most common sites of metastases in patients with advanced lung cancer. Skeletal complications may cause significant morbidity and decrease performance status (PS). Such complications, referred to as skeletal related events (SREs), include severe bone pain, pathological fractures, spinal cord compression, and hypercalcemia of malignancy. We assessed the clinical impact of SREs in non-small lung cancer (NSCLC) patients with bone metastases. Methods: We retrospectively investigated the clinical records of all 120 patients who were diagnosed advanced NSCLC with bone metastases between June 1998 and March 2009. Results: A total of 23 patients (26.7%) were found to have SREs at the time of initial diagnosis. The median survival time (MST) was 123 days for patients with SREs, while it increased to 276 days for those without SREs. The MST of the patients with SREs were significantly shorter than that of the patients without SREs (p<0.001). We also studied the SREs during clinical courses of 89 patients whose records were available over 3 months. A total of 39 patients (43.8%) were found to have SREs during clinical courses. Conclusion: The patients in NSCLC with bone metastases were often found to have SREs. SREs cause significant morbidity and deterioration of PS. Systemic chemotherapy could not decrease SREs during their clinical courses. Further studies evaluating bisphosphonates in combination with chemotherapy are warranted. Palliat Care Res 2010; 5(2): 145-151
3.From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers.
Fariz NURWIDYA ; Fumiyuki TAKAHASHI ; Kunihiko MINAKATA ; Akiko MURAKAMI ; Kazuhisa TAKAHASHI
Anatomy & Cell Biology 2012;45(2):73-78
Hypoxia, defined as a decrease of tissue oxygen levels, represents a fundamental pathophysiological condition in the microenvironment of solid tumors. Tumor hypoxia is known to be associated with radio/chemo-resistance and metastasis that eventually lead to cancer progression contributing to poor prognosis in cancer patients. Among transcription factors that accumulated under hypoxic conditions, hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that has received the most intense attention in this field of research due to its capacity to modulate several hundred genes. With a clearer understanding of the HIF-1 pathway, efforts are directed at manipulation of this complex genetic process in order to ultimately decrease cellular HIF-1 levels. Some novel agents have been shown to have HIF-1 inhibition activity through a variety of molecular mechanisms and have provided promising results in the preclinical setting.
Anoxia
;
Genetic Processes
;
Humans
;
Neoplasm Metastasis
;
Oxygen
;
Prognosis
;
Transcription Factors
4.From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers.
Fariz NURWIDYA ; Fumiyuki TAKAHASHI ; Kunihiko MINAKATA ; Akiko MURAKAMI ; Kazuhisa TAKAHASHI
Anatomy & Cell Biology 2012;45(2):73-78
Hypoxia, defined as a decrease of tissue oxygen levels, represents a fundamental pathophysiological condition in the microenvironment of solid tumors. Tumor hypoxia is known to be associated with radio/chemo-resistance and metastasis that eventually lead to cancer progression contributing to poor prognosis in cancer patients. Among transcription factors that accumulated under hypoxic conditions, hypoxia-inducible factor-1 (HIF-1) is a master transcription factor that has received the most intense attention in this field of research due to its capacity to modulate several hundred genes. With a clearer understanding of the HIF-1 pathway, efforts are directed at manipulation of this complex genetic process in order to ultimately decrease cellular HIF-1 levels. Some novel agents have been shown to have HIF-1 inhibition activity through a variety of molecular mechanisms and have provided promising results in the preclinical setting.
Anoxia
;
Genetic Processes
;
Humans
;
Neoplasm Metastasis
;
Oxygen
;
Prognosis
;
Transcription Factors
5.Minimally invasive radical hysterectomy and the importance of avoiding cancer cell spillage for early-stage cervical cancer: a narrative review
Atsushi FUSEGI ; Hiroyuki KANAO ; Shiho TSUMURA ; Atsushi MURAKAMI ; Akiko ABE ; Yoichi AOKI ; Hidetaka NOMURA
Journal of Gynecologic Oncology 2023;34(1):e5-
Radical hysterectomy is a standard surgery to treat early-stage uterine cervical cancer. The Laparoscopic Approach to Cervical Cancer (LACC) trial has shown that patients receiving minimally invasive radical hysterectomy have a poorer prognosis than those receiving open radical hysterectomy; however, the reason for this remains unclear. The LACC trial had 2 concerns: the learning curve and the procedural effects. Appropriate management of the learning curve effect, including surgeons’ skills, is required to correctly interpret the result of surgical randomized controlled trials. Whether the LACC trial managed the learning curve effect remains controversial, based on the surgeons’ inclusion criteria and the distribution of institutions with recurrent cases. An appropriate surgical procedure is also needed, and avoiding intraoperative cancer cell spillage plays an important role during cancer surgery. Cancer cell spillage during minimally invasive surgery to treat cervical cancer is caused by several factors, including 1) exposure of tumor, 2) the use of a uterine manipulator, and 3) direct handling of the uterine cervix. Unfortunately, these issues were not addressed by the LACC trial. We evaluated the results of minimally invasive radical hysterectomy while avoiding cancer cell spillage for early-stage cervical cancer. Our findings show that avoiding cancer cell spillage during minimally invasive radical hysterectomy may ensure an equivalent oncologic outcome, comparable to that of open radical hysterectomy. Therefore, evaluating the importance of avoiding cancer cell spillage during minimally invasive surgery with a better control of the learning curve and procedural effects is needed.